LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

Kodu・Aktsiate loetelu・PerkinElmer Inc

PerkinElmer Inc

Suletud

SektorTervishoid

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

Max

Põhinäitajad
By Trading Economics
Sissetulek	-8.6M 47M
Müük	-21M 699M
P/E Sektori keskmine	52.799 80.03
Aktsiakasum	1.18
Dividenditootlus	0.27
Kasumimarginaal	6.675
Töötajad	11,000
EBITDA	-14M 181M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+10.78% upside

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	0.27% 2.29%
Järgmine aktsia dividendi kuupäev (ex-date)	16. jaan 2026

Turustatistika
By TradingEconomics
Turukapital	612M 12B
Eelmine avamishind	0
Eelmine sulgemishind	0

Uudiste sentiment

By Acuity

33%

67%

103 / 374 Pingereas Healthcare

PerkinElmer Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

9. dets 2025, 22:13 UTC

Tulu

GE Vernova Raises Outlook, Doubles Dividend on Energy Market Momentum

9. dets 2025, 21:40 UTC

Tulu

GameStop Sales Fall as Collectibles Remain Only Bright Spot

9. dets 2025, 18:51 UTC

Omandamised, ülevõtmised, äriostud

Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical

9. dets 2025, 16:57 UTC

Suurimad hinnamuutused turgudel

Clear Secure Rises on Medicare Identity Verification Contract

9. dets 2025, 23:46 UTC

Market Talk

Nikkei May Trade Rangebound Ahead of Fed Rate Decision -- Market Talk

9. dets 2025, 23:46 UTC

Omandamised, ülevõtmised, äriostud

Legend Holdings Stake in Lenovo Now at 32.34%

9. dets 2025, 23:45 UTC

Omandamised, ülevõtmised, äriostud

Legend Holdings: Remains Optimistic About Lenovo's Future Development Potential

9. dets 2025, 23:44 UTC

Omandamised, ülevõtmised, äriostud

Legend Holdings: Purchased Lenovo Shares at Average Price of HK$9.7653/Share

9. dets 2025, 23:43 UTC

Omandamised, ülevõtmised, äriostud

Legend Holdings: Acquired Lenovo Shares for Total Cash Consideration of HK$1.12B

9. dets 2025, 23:43 UTC

Omandamised, ülevõtmised, äriostud

Legend Holdings: Acquired 115.17M Lenovo Shares From Open Market Between Nov. 21 and Dec. 9

9. dets 2025, 23:35 UTC

Market Talk

Gold Edges Higher Ahead of FOMC Decision -- Market Talk

9. dets 2025, 22:42 UTC

Tulu

PepsiCo Wants to Boost Sales, Cut Costs. The Street Is Doubtful. -- Barrons.com

9. dets 2025, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

9. dets 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9. dets 2025, 21:48 UTC

Market Talk

Hiring Confidence Slips in Canada Entering 2026 -- Market Talk

9. dets 2025, 21:36 UTC

Tulu

Casey's General Stores: Fiscal 2026 EBITDA Is Expected to Increase 15% to 17% >CASY

9. dets 2025, 21:36 UTC

Tulu

Casey's General Stores: Total Inside Gross Profit Increased 13.5% to $703.4M Compared to Prior Yr >CASY

9. dets 2025, 21:36 UTC

Tulu

Casey's General Stores: Now Expects Inside Same-Store Sales to Increase 3% to 4% and an Inside Margin of 41% to 42% >CASY

9. dets 2025, 21:36 UTC

Tulu

Casey's General Stores: Same-Store Fuel Gallons Up 0.8% Compared to Prior Yr With Fuel Margin of 41.6 Cents per Gallon, Total Fuel Gross Profit Increased 20.9% to $377.4M Compared to Prior Yr >CASY

9. dets 2025, 21:36 UTC

Tulu

Casey's General Stores: Inside Same-Store Sales Increased 3.3% Compared to Prior Yr, and 7.5% on 2-Yr Stack Basis, With an Inside Margin of 42.4% >CASY

9. dets 2025, 20:28 UTC

Market Talk

Oil Futures Decline for Second Straight Session -- Market Talk

9. dets 2025, 20:27 UTC

Omandamised, ülevõtmised, äriostud

Teck Resources: Merger of Equals With Anglo Amer Plc Approved by Both Classes of Teck Hldrs

9. dets 2025, 20:27 UTC

Omandamised, ülevõtmised, äriostud

Teck Reports Voting Results From Special Meeting of Hldrs

9. dets 2025, 20:26 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Moody's: Paramount's Warner Bid Makes Strategic Sense, With Risk -- Market Talk

9. dets 2025, 20:21 UTC

Market Talk

U.S. Natural Gas Extends Pullback on Shifting Weather Outlook -- Market Talk

9. dets 2025, 19:52 UTC

Tulu

Correction to 58 S&P 500 Stocks Have Dividends Higher Than Treasuries. 10 Look Better Than Bonds. -- Barrons.com on Dec. 8

9. dets 2025, 19:17 UTC

Tulu

Update: 58 S&P 500 Stocks Have Dividends Higher Than Treasuries. 10 Look Better Than Bonds. -- Barrons.com

9. dets 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

9. dets 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

9. dets 2025, 17:11 UTC

Tulu

Nvidia Has Permission to Sell H200 Chips to China. Why It Might Not Matter Much for the Stock. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

PerkinElmer Inc Prognoos

Hinnasiht

By TipRanks

10.78% tõus

12 kuu keskmine prognoos

Keskmine 110.55 USD 10.78%

Kõrge 125 USD

Madal 100 USD

Põhineb 12 Wall Streeti analüütiku instrumendi PerkinElmer Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

12 ratings

Osta

Hoia

Müü

Põhineb 12 analüütiku instrumendi PerkinElmer Inc aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

103 / 374 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest PerkinElmer Inc

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.